Antonio Strafella | University of Toronto, Toronto, ON, Canada
Thilo Van Eimeren | University of Cologne, Germany
Abstract
Differential diagnoses between Parkinsonian syndromes pose significant challenges for clinicians as clinical manifestations can overlap and there are no gold standard biomarkers. Multimodal translational approaches from novel molecular makers using positron emission tomography (PET) to the brain connectomics by means of magnetic resonance imaging (MRI) could help to elucidate the underlying brain mechanisms of parkinsonisms and their clinical prognoses.
Dr. Raquel Jimenez Pasalodos - Universidad de Valladolid and Universitat de Barcelona (ERC Artsoundscapes project)
The poster of this talk can be downloaded from here
Tobias Reichenbach, PhD | Imperial College London
Abstract
Understanding speech in noisy backgrounds requires selective attention to a particular speaker. Humans excel at this challenging task, while current speech recognition technology still struggles when background noise is loud. The neural mechanisms by which we process speech remain, however, poorly understood, not least due to the complexity of natural speech. Here we describe recent progress obtained through applying machine-learning to neuroimaging data of humans listening to speech in different types of background noise. In particular, we develop statistical models to relate characteristic features of speech such as pitch, amplitude fluctuations and linguistic surprisal to neural measurements. We find neural correlates of speech processing both at the subcortical level, related to the pitch, as well as at the cortical level, related to amplitude fluctuations and linguistic structures. We also show that some of these measures allow to diagnose disorders of consciousness. Our findings may be applied in smart hearing aids that automatically adjust speech processing to assist a user, as well as in diagnostics of brain disorders.
Chris Butler |Imperial College London/University of Oxford
Abstract
Memory impairment is common in neurological disease and is often associated with hippocampal pathology. Pure hippocampal amnesia is, however, relatively rare and its underlying mechanisms are controversial. I will discuss research from patients with both transient and persistent forms of amnesia, which provide insights into memory impairment more broadly and from whom important clinical lessons can be learned. In particular, I will argue that many neuropsychological tests of memory are neither sensitive nor specific to hippocampal disease. Instead, we should be measuring forgetting over prolonged periods of time. Accelerated long-term forgetting is a novel and highly sensitive cognitive marker of preclinical Alzheimer’s disease.
Dr. Martijn Wokke |The City University of New York (USA), and The University of Cambridge (UK)
Gina Rippon | Aston University
Manuel Mameli, PhD - Université de Lausane
Abstract
To delineate the neuronal circuits underlying aversion and reward, and their implications in neuropsychiatric disorders is a current hot-topic in neuroscience. The Mameli’s lab aims to decipher the neurobiology of motivation and provide knowledge for disorders including addiction and depression by using different approaches such as electrophysiology, optogenetics, rodent behavior and molecular biology.
Rebecca Carrier, Professor and Associate Chair for Research, Chemical Engineering, Northeastern University, Boston, USA
Abstract
The intestinal mucosal barrier is Transport phenomena in the intestine are highly significant to effective oral drug delivery, nutrient absorption, and interactions between microbes and intestinal tissue. Our in vitro models. Interactions between intestinal lumen contents, including food and microbes, with underlying tissues are currently studied in animal models or simple in vitro culture systems that are limited in their representation of phenomena occurring in the human gut. Thus, we are developing in vitro human gut models that incorporate the microbiome and key cell types (e.g., immune cells) as well as appropriate physical stimuli (e.g., fluid flow). One aspect of permeation through the intestinal membrane, transport through mucus, is being investigated in detail. Results to date highlight the dependence of mucosal permeation on physical and chemical properties of penetrating material (drug, particle, microbe) as well as the significance of intestinal lumen contents in altering the mucus barrier. Our findings suggest that mild stimuli, such as those presented by food, can modulate the intestinal mucosal barrier, for example to impact oral drug delivery or microbial invasion, as occurs in infection and intestinal inflammation
Deadline to get enrolled: 27 February
Register here
The objective of the workshop is to have an overview of the Postdoctoral opportunities offered by the European, Spanish and Catalan system and provide the participants with the necessary tools to find a Postdoc anywhere. The number of participants is limited to 20 people to guarantee the quality of the workshop. Junior Postdocs and PhD students at the end of their PhD programme under the supervision of a member of the Institute will be prioritized. Your admission will be confirmed as soon as possible and no later than a week before the workshop.
Deadline to get enrolled: 4 March
Register here
The objective of the workshop is to have an overview of the Postdoctoral opportunities offered by the European, Spanish and Catalan system and provide the participants with the necessary tools to find a Postdoc anywhere. The number of participants is limited to 20 people to guarantee the quality of the workshop. Junior Postdocs and PhD students at the end of their PhD programme under the supervision of a member of the Institute will be prioritized. Your admission will be confirmed as soon as possible and no later than a week before the workshop.
Proposal Submission Deadline: Monday, May 20, 2019 – 23:59 HAST
Dilluns, 23 de novembre
· Nombres i bits contra la pandèmia
Dimarts, 24 de novembre
· La nanotecnologia contra la COVID-19 i molt més enllà
· L'alimentació en temps de COVID-19
Dimecres, 25 de novembre
Dijous, 26 de novembre
Divendres, 27 de novembre
· La pandèmia informativa i comunicativa
Dr Mariela Trinchero | Fundación Instituto Leloir
La Jornada de presentación de Horizonte Europa en España se celebrará durante las mañanas de los días 2 y 3 de diciembre y se retransmitirá a través de Internet. La agenda de la Jornada e inscripciones están disponibles a través del siguiente enlace.
El objetivo fundamental de la Jornada es dar a conocer a las entidades españolas los objetivos, la estructura y las prioridades de Horizonte Europa, el próximo Programa Marco de Investigación e Innovación de la Unión Europea para el periodo 2021-2027.
El evento está organizado por el CDTI y el Ministerio de Ciencia e Innovación, con la colaboración de la Comisión Europea y la FECYT.
Here you have a funny opportunity to learn what investors expect from you and how to give it to them:
- Gain key insights on how to pitch to investors
- Let a VC describe what your first date with an investor is going to be like
As part of the initiative “Brain Health for Life” (15-16D), we have organized this informal webinar:
Nailing your first meeting with investors
Wednesday 9th Dec from 16h to 17:30h CET
Agenda:
16 - 16:20h Pilar Puig, Biocat. From the entrepreneur’s side: How to prepare your pitch, pitch deck & one-pager
16:20 - 16:40h Laura Rodríguez, In Vivo Ventures. Interaction with VCs: First meeting and evaluation process
16:40 - 17h Q&A
17-17:30h - Pitches of projects/companies participating at Brain Health for Life. Chair: Núria Martí, Director of Innovation, Biocat
Register HERE for free!
This webinar is part of ToHealth program, an EIT Health activity. The course is organized by Biocat, Institut Guttmann and “la Caixa” Foundation, with the collaboration of the Institute of Neurosciences of the Universitat de Barcelona, Meditecnologia and Medicen Paris, under the framework of B·Debate.